User profiles for S. Badola

Shalini Badola

Indian Institute of Science Education and Research
Verified email at iiserb.ac.in
Cited by 84

New loci associated with kidney function and chronic kidney disease

…, M Nauck, U Völker, O Polasek, V Vitart, S Badola… - Nature …, 2010 - nature.com
Chronic kidney disease (CKD) is a significant public health problem, and recent genetic studies
have identified common CKD susceptibility variants. The CKDGen consortium performed …

Meta-analysis of genome-wide association studies in> 80 000 subjects identifies multiple loci for C-reactive protein levels

…, JF Keaney, W Sun, AP Sarin, JD Fontes, S Badola… - Circulation, 2011 - Am Heart Assoc
Background— C-reactive protein (CRP) is a heritable marker of chronic inflammation that is
strongly associated with cardiovascular disease. We sought to identify genetic variants that …

[HTML][HTML] Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women

…, M Kellogg, RYL Zee, N Rifai, S Badola… - PLoS …, 2008 - journals.plos.org
… receptor(s) and/or decrease its secretion, perhaps by decreasing its affinity for the protease(s)
… might be the result of the presence of the A antigen on its receptor(s) and/or protease(s). …

Sb3+–Er3+‐Codoped Cs2NaInCl6 for Emitting Blue and Short‐Wave Infrared Radiation

S Saikia, A Joshi, H Arfin, S Badola… - Angewandte …, 2022 - Wiley Online Library
… Here we introduce such functionalities in Cs 2 NaInCl 6 by codoping Sb 3+ (s-electron … it
has two s-electrons (5s 2 ) in the outermost orbitals. Upon excitation, one of the s-electrons goes …

[HTML][HTML] Phase II study of Ganitumab, a fully human anti–type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or …

…, I Leitch, S Badola, S Chang… - Journal of Clinical …, 2012 - scholarship.miami.edu
Purpose Ganitumab is a fully human monoclonal antibody against type-1 insulin-like growth
factor receptor (IGF1R). An open-label phase II study was conducted to evaluate the efficacy …

[HTML][HTML] Randomized phase II study of paclitaxel plus alisertib versus paclitaxel plus placebo as second-line therapy for SCLC: primary and correlative biomarker …

…, EF Kong, M Williams, S Badola… - Journal of Thoracic …, 2020 - Elsevier
Introduction We assessed the Aurora A kinase inhibitor, alisertib, plus paclitaxel (henceforth
referred to as alisertib/paclitaxel) as second-line treatment for SCLC. Methods In this double-…

CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes

…, M Ryan, A McDonald, S Badola… - The Journal of …, 2006 - journals.aai.org
… Total RNA was isolated using RNAeasy technology on a Biorobot 8000 workstation and
DNase treated according to the manufacturer’s protocol (Qiagen). The purity and yield of the …

[HTML][HTML] Riverine plastic pollution from fisheries: Insights from the Ganges River system

…, S Patel, R Badola, S Bhola, S Chakma… - Science of the Total …, 2021 - Elsevier
… (1), where S V is the final vulnerability score, S D is the gear density score, S R is the IUCN
Red List score and S L is the literature-based evidence score)… (1) S V = S D × S R × S L …

The JAMM motif of human deubiquitinase Poh1 is essential for cell viability

…, JA Gutierrez, JC Pulido, D Rappoli, S Badola… - Molecular cancer …, 2007 - AACR
… Louis, MO) and cycling parameters of an initial 95C for 2 min and then 40 cycles of 95C for
20 s, 58C for 20 s, and 76C for 20 s. Data were analyzed using SDS 1.7 (Applied Biosystems) …

Putative predictive biomarkers of survival in patients with metastatic pancreatic adenocarcinoma treated with gemcitabine and ganitumab, an IGF1R inhibitor

…, Y Tudor, H Deng, R Tang, S Suzuki, S Badola… - Clinical Cancer …, 2013 - AACR
… Suzuki, and S. Badola are former employees of and are shareholders in Amgen Inc. HL
Kindler is an advisor for Amgen Inc. CS Fuchs is an advisor for Amgen Inc., ImClone Systems, …